MLchartDataset catalogue

Idhifa

Term · Oncology and biomedicine · MLC-T-ONC-004127

A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment. It is used in patients whose cancer has a mutation (change) in the IDH2 gene. It is also being studied in the treatment of other types of cancer. Idhifa blocks the protein made by the mutated IDH2 gene. Blocking this protein may help keep cancer cells from growing. Idhifa is a type of enzyme inhibitor. Also called enasidenib mesylate.

Table 1. Record
IdentifierMLC-T-ONC-004127
FieldOncology and biomedicine
Synonymsenasidenib mesylate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004127",
  "term": "Idhifa",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment. It is used in patients whose cancer has a mutation (change) in the IDH2 gene. It is also being studied in the treatment of other types of cancer. Idhifa blocks the protein made by the mutated IDH2 gene. Blocking this protein may help keep cancer cells from growing. Idhifa is a type of enzyme inhibitor. Also called enasidenib mesylate.",
  "synonyms": [
    "enasidenib mesylate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/idhifa/"
}

Record 8,931 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.